FDA Issues Recall Advisories Over 4 Penis Pill Brands

FDA Issues Recall Advisories Over 4 Penis Pill Brands
Rhett Pardon

WASHINGTON — The Food and Drug Administration yesterday posted more advisory warnings for penis pills.

The FDA issued advisories over single blister packs of RezzRX from Fossil Fuel Products and lots from Rhino 5 Plus, Maxtremezen and Extenzone from Jobbers Wholesale.

So far, the FDA has issued advisories for at least 41 penis pill brands over mislabeling since the beginning of the year.

FDA analysis found Rhino 5 Plus, Maxtremezen and Extenzone  to contain the undeclared erectile-dysfunction drug desmethylcarbondenafil and dapoxetine, which also was undeclared and is typically used to treat depression.

RezzRX was found to contain erectile-dysfunction drugs hydroxylthiohomosildenafil and amionotadalafil, the FDA says.

Both Fossil Fuel Products and Jobbers Wholesale have issued nationwide recalls because of the undeclared ingredients.

Related: